Rui Jiang
Corporate Secretary bij JINKO SOLAR CO., LTD.
Profiel
Rui Jiang currently works at Cali Biosciences Co. Ltd., as Non-Executive Director from 2021 and Jinko Solar Co., Ltd., as Secretary from 2021.
Mr. Jiang also formerly worked at Bloomage Biotechnology Corp.
Ltd., as Board Secretary, Director & Deputy General Manager from 2019 to 2020.
Mr. Jiang received his graduate degree in 2008 from Renmin University of China.
Actieve functies van Rui Jiang
| Bedrijven | Functie | Begin |
|---|---|---|
| JINKO SOLAR CO., LTD. | Corporate Secretary | 07-01-2021 |
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Director/Board Member | 17-03-2021 |
Eerdere bekende functies van Rui Jiang
| Bedrijven | Functie | Einde |
|---|---|---|
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | Director/Board Member | 25-12-2020 |
Opleiding van Rui Jiang
| Renmin University of China | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | Process Industries |
| JINKO SOLAR CO., LTD. | Electronic Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |
